| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |